tiprankstipranks
Barclays Reaffirms Their Buy Rating on Keurig Dr Pepper (KDP)
Blurbs

Barclays Reaffirms Their Buy Rating on Keurig Dr Pepper (KDP)

Barclays analyst Lauren Lieberman maintained a Buy rating on Keurig Dr Pepper (KDPResearch Report) yesterday and set a price target of $32.00. The company’s shares closed yesterday at $29.30.

Lieberman covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Colgate-Palmolive, and PepsiCo. According to TipRanks, Lieberman has an average return of 1.9% and a 51.99% success rate on recommended stocks.

In addition to Barclays, Keurig Dr Pepper also received a Buy from Wells Fargo’s Christopher Carey in a report issued on February 29. However, on February 27, TD Cowen assigned a Hold rating to Keurig Dr Pepper (NASDAQ: KDP).

See Insiders’ Hot Stocks on TipRanks >>

KDP market cap is currently $40.43B and has a P/E ratio of 18.92.

Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of KDP in relation to earlier this year. Earlier this month, Robert S. Singer, a Director at KDP sold 14,132.00 shares for a total of $413,341.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Keurig Dr Pepper (KDP) Company Description:

Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.

Read More on KDP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles